By Hugh Son
At a Glance
- Visa struck a deal on Aug. 3, 2026, to pay $2.4 billion in cash for BioCatch, with Permira, a London-based private-equity firm, heading a seller group that includes additional stakeholders.
- The purchase is driven by BioCatch's behavioral biometrics, which looks at typing cadence, swipes, and how a device is held to stop fraud before payment.
- The purchase fits Visa's broader push into value-added services beyond simply processing transactions.
The acquisition deepens Visa's cybersecurity push.
The core asset in the deal is BioCatch's behavioral biometrics offering.
The platform is meant to stop fraudulent payments before they are sent.
The purchase comes as lenders deal with a growing wave of AI-powered scams and account takeovers.
Visa says generative AI lowers the cost of attacks, speeds them up, and makes them more believable.
Get the market news that matters in a five-minute read with Market Briefs, our free daily newsletter
The company calculates that scam losses and account takeovers exceed $1 trillion a year worldwide.
The transaction also shows how payment firms are rushing to strengthen anti-fraud defenses.
BioCatch made the same point in a blog post published alongside the news. "The reality is, as a society and industry, we are not winning this fight," the firm said. "The value of fraud and scam losses and the number of fraud and scam attempts, mule accounts, and victims of these financial crimes all continue to grow (in some cases, exponentially) every year, all around the world."
BioCatch said in the post that becoming part of Visa will let it expand its reach as fraud continues to climb globally.
Visa's network connects nearly 14,500 financial institutions and processes over 329 billion transactions per year, representing more than $17 trillion in value.
In a statement, Andrew Torre, who leads Visa's value-added services business, said: "BioCatch will help our clients stop fraud before it reaches the point of payment."
The deal is still pending, and no additional financial terms were disclosed.
Background
BioCatch is headquartered in Tel Aviv and specializes in behavioral biometrics, a fraud-fighting approach that analyzes typing cadence, swiping style, and how a device is held. Its platform is already used by around 350 banks to protect about 760 million users. Visa has been expanding its value-added services unit, which sells security and analytics tools to banks, and the acquisition is meant to strengthen that business as AI-powered fraud grows. Regulatory review still lies ahead, and Visa expects completion during its fiscal second quarter of 2027.
BioCatch says its platform helps banks spot fraudulent behavior before payment is completed. Visa's network connects nearly 14,500 financial institutions, creating a large channel for that technology. The deal is part of a broader move by payment firms to sell anti-fraud services rather than just process transactions.
Why It Matters
The acquisition places BioCatch's behavioral biometrics directly inside the value-added services unit, which already sells security and analytics tools to banks.
Adding BioCatch also builds on Visa's existing fraud and risk tools as AI-powered threats become more common.
Join Market Briefs, our free daily newsletter, for a quick daily rundown of the markets
